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Cryptococcosis after renal transplantation: 
Report of ten cases 
Gerhard P. J. Schroter, ~fKaKI Donald R. Temple, .M.D., Bo S. Husberg, M.D., Richard Weil, III, 
M.D., and Thomas E. Starzt, M.D., Ph.D., Dcm'er, Colo. 
Tm cases of CI")Ploco((osis hat'e hem identified ill a 1; ;ear expr'lifllce u'ith more than 
650 rmaltrall.-,plalltJ. Eight paticilts had 71I!'11illgitiJ, 0111' patil'llt had a cerebral 
gJ'allllloma, alld ill olle patimt Ihl! infalioll appeared to be limited to flU' lungs. The 
(t'lItrallll.'nJollS 5)'stCI11 illfection often /1/G5queradl!d as brain tumar and was not suspected 
illitiall),. The most us/fill diagllostic test ;cas cerebrospinal fluid examination including 
India illk preparation. f'ariollS thn-apeutic regimens u'ith ol11phOli/icin B and 
'-jluorocytosille u.'ere effective ill suppressi11g the infection. A combil/atioll of low doses of 
amphotericin B, not affecting kidneyfunction, with 5-jlUOTOcyto.,ine Jor at least J 
1I10nths u'as associated v.'ith remissioll of disease in five patil!lI1s "J.·ho still are alive, 
including three patifllts u'ithout recurre11ce for longer than one yar. Five deaths J weeks 
to 4 Jears after the bCgi1illillg of treatllll'llt were not due to CT)'P!ococcosis; death resulted 
from vascular disease and septicemia ill three of the four patief/Is with knou'n causes of 
death. Central/tel'Jous S)stem cl)·pto(occosis, with the exception of the Tare cerebral 
granuloma, is associatcd ".L'ith little illftammation. If cad)' death from increased 
intracranial pressure or cerebral edema is prevented, prolollged thera/')' with amphotericin 
Band 5-jluorocJtosillc ma)' be expected to colltrolthe infectioll, eren in 
immunosuppressed patients. . 
From the Departme1lts of Pediatrics al!d Surgery. Unil.'mity of Colorado Medical Cn;:t'T, and tht 
11et/ran's Admil1;"'lration Hospital, Drlll'tlr, Colo. 
AT THE University of Colorado ~fedical Center and 
the Denver Veteran's Administration Hospital, more 
than 650 kidney transplants haye been done from 1962 
through 1974. Prednisone and azathioprine ha\'e been 
the main drugs used for immunosuppression, al-
though initially prednisone was reserved for rejection 
crises. AJ:'!tilymphocytic globulin was added in 1966, 
and cyclophosphamide has been substituted for 
azathioprine in some patients since 1971.. Rejection 
episodes have been treated by temporary increase~ of 
the daily prednisone dose, usually to 200 mg. follo\\'ed 
by 10 to 20 mg. daily reductions and/or b}' imravenous 
infusions of 1 Gm .. of methylprednis()lone .. In addition, 
some rejection episodes have been treated by graft 
irradiation (150 r x 3) or by actinomycin D .. 37 
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CASE MATERIAL 
During the past 13 years, including the first 2 
months of 1975, ten cryptococcal infections have been 
identified and treated in eight men and one woman 
(B. ~KFI ages 2i to 51 years, and in one 12-year-old 
girl (C. S .. ) (Table I). Three of these patients (E. T., 
. R. 1\.., C. S.) had received more than one renal trans-
plant before the diagnosis of cryptococcosis. 
In eight patients the infection appeared after 
long-term immunosuppression during the third to 
tenth year after transplanration. In the other u\·o 
patients the diagnosis was made during the fourth 
(B .. K) and tenth months U. H.) after transplantation. 
Immunosuppression. At the time of diagnosis of 
Vol. 79, No. J. pp. 268 .. 277 
""DffDDD:~ i9 
Ky·!;t!~"Er J 
ill fectioi1. all patieJlts were receiving maiJlten:1Ilce 
prc:dnisone and azathioprine. Olle patient (B. X.) still 
\,as receivillg alltilymphocytic globulin injectiolls. In 
three patients (E. T., W. S., C. S.). a temporary increase 
of the daily prednisone dose preceded exacerbation of 
symptoms. In another patient (L. 0.), the onset of 
symptor:\s fullowed 3 months of "'eeldy infusions of 
meth}'lprednisolone (I Gm.) in addition to mainte-
nance immunosuppression. 
Organ involvement. The central nen'ous system was 
affected in nine parients; there was meningitis in eight 
and a brain granuloma in one patient (Table II). The 
lungs were simultaneously involved in thl'ee patients 
(E. T., L. 0., J. H.); Cryptococci were found in the 
urine of two of the three parients (M. La., C. S.) whose 
urines were cultured for fungi. The infection appeared 
to be confilled to the lungs in one patienr E~1K Li.). 
Fever was detected in only three patients (B. ~KI W. S., 
C. S.). 
Pulmollary CI}ptococcosis. The pulmonary infection 
was recognized as indistinct nodular infiltrates in three 
patients (E. T., J. B., M. Li.), two of whom had positive 
sputum cultures (E. T.. ~1K Li.). The infiltrates were 
detected on chest x-rays taken for suspected pulmo-
nary embolus ill one patient (1\1. Li.) and in the other 
two patients on routine films taken 2 months before 
and one month after the detection of cryptococcal 
meningitis. 
Ct'lllralllervOllJ sJStem CI)"ptococcosis. The most common 
symptom of central nervous system infection was 
headache, "hich occulTed in eight of the nine patients. 
The headaches antedated additional symptoms by 
weeks or months in four patient!> (E. T., W. S., C. S., 
J. H.). Other manifestations included memory loss, 
disorientation, confusion, dyscalculia, dysphasia, mus-
cle weakness, unsteadiness, tremor, urinary inconti-
nence, behavioral and emotional disturbances. Focal 
neurological signs included hemiparesis, truncal and 
limb ataxia. nystagmus. intermittent diplopia, dysar-
thria, and right-left disorientation. Four patients (B. 
::'\ .. L 0 .. W. S., J. H.) had seizures. Bizarre beha\'ior, 
hallucinations. and disorientation were so prominent 
in one p;)tient (R. K.) that he \,'as thought to have a 
steIoic\·induced ps~chosis hefore the correct diagnosis 
was made about 4 weeks after the onset of symptoms. 
Another patient (L. 0.) \\as evaluated for two episodes 
of transient hemiparesis or p:tresthesias and aphasia 
and had abnormal ct"rt'brospinal fluid;) months before 
tlat' ,'iagnosis \,'as made. 
Papilledema was Hoted in four patients (B. X., E. T., 
W. S., J. 1-1.). Acute neurological deterioration and 
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Table I 
11l1~rK·ElD bfl-a'un 
tramplontalion 
Case .-Igt and diagrwlis of 
So. Patifllt (yr.) s .. x Donor inji-clion 
1 J. H. 27 ~! Sister 10 mo. 
2 B. ~K 29 F Sister 3Vt mo. 
3 R. K. 48 M Son 2 yr., 6 mo. 
Cadaver 1 yr., S mo. 
Cadaver 1 yr., 3 mo. 
4 ~i La. 42 M Unrelated 6 yr., 9 mo. 
living 
5 L. O. 33 M Brother 4 yr. 
6 W.S. 34 1\1 COllsin 9 yr., 7 mo. 
7 E. T. 43 ~f Brother 5 yr. 
Cada\er 8 mo. 
S C. S. 12 F Mother 4 yr. 
Cada\'er 7 mo. 
9 r.. W. 49 M Cadaver 5 yr., 5 mo. 
10 M. Li. 51 M Cadaver 3 yr., 7 mo. 
appearance of papilledema wel'e observed in two 
patients ,\"ith chronic headaches (E. T., W. S.) after 
temporary increases of corticosteroid for rejection 
episodes. 
Two other patients (J. H., B. N.) developed progres-
sively increased intracranial pressure; in one patient 
(B. ::'\.) partial loss of vision was due to thrombosis of 
branches ofthe retinal veins, in the other patient (J. H.) 
ventriculoperitoneal shunt was required and \\'as 
complicated by cardiorespiratory anest. 
Laboratory studies. Skull x-rays showed an erosion 
of the sella turcica of one patient (E. T.). a 7 111m. shift 
of the pineal gland to the right in another patient (E. 
\\'.). and c2.lcifzcations in the area of the choroid plexus 
in a third patient (B. X.). 
Eight patients had brain scans done \,·ith technitium 
pertechnetate. In one patient (Eo W.), a space-oc-
cupying le;ion with increased isotope uptake and 
cold center ,,'as found in the left frontal lobe. Brain 
scans of other patients showed a diffuse increase of 
isotope uptake O\'er the brain surface (B. K) and a 
localilc:d i!lCl"ea;;e of isotope upt:lke over the left 
occipital lobe \ R. K.). 
Electroencephalograms of all nine patients with 
central nen'ous system cryptococcosis sho\\'ed some 
slO\\ing and di,organizarion of electrical acthity \,ith 
focal predominance in fOllr and paroxysmal activity in 
two p:uienb. 
CerdJra! al1giograms \,ere done 011 six patients. Tht.' 
angil.graIn (onfirmed the one focal lesion detected by 
scali (E. \\'.j. Angiographic abnormalities in other 
patients here dcla~Decl filling of the left rhobndic win 
~~ttDI~ 
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Table 11. Organ im·ohemellt. duration of s~ mptoms, outcome of treatment, and major complications in ten renal 
tr.lIlSplant recipients with cnptococcosis 
Duratiun o{'ymprulI/s 
Cast 640'-1' di'l;nosis 
.\'0. Paliml Orgal/ i1l1:0""'1/11'111 and trfalml'II! 
J. H. ~feningesI lungs 6 ,,-I;.. 
2 B. ~K ~feninges 7 wk. 
3 R. K. Meninges -I wk. 
-l ~1K La. ~feninges 3 ,,'k. 
5 L.O. !lleninges. :> mo. 
mediastinal 
lymph nodes 
6 \\'.S. Meninges 2 mo. 
i E. T. Meninges. lungs Sel'eral mo. 
8 C.S. :\Ieninges Sel'eral mo. 
9 E.\\'. Cerebral 6 wk. 
granuloma 
10 !II. Li. Lungs Se\eral mo. 
and adjacent sagittal sinus (W. S.) and irregularities in 
an erial outlines (;\1. L.). 
Two patients were subjected to pneumoencephalog-
r.:lphy. In one patient studied \'ia lumbar puncture, 
a mild dilatation of the fourth \'entricle \,'as seen 
(B. ~ .). The other patient was studied by \'entricular 
puncture \\'ith the finding of mild dilatation of the 
lateral \'entricles and obstruction of the basilar cystern 
(j. H.). 
Lumbar punctures were performed in all but one 
patient (E. \V.) (Table III). The cerebrospinal fluid 
pressure usually was increased. and most patients \dlh 
c~ptococcal meningitis had a mild lymphocytic 
pleocytosis. elevated protein, and decreased glucose 
concentration. A borderline protein concentration of 
4~ mg. per 100 ml. (R. K.) or a decreased glucose 
concentration of 30 mg. per 100' ml. (B. :\.) \,ere the 
only abnormalities founel in t,,'o patients with c~p­
tococcal meningitis. CrJPforo(cuJ lll'oJonl/GI/S was isolated 
from cultures of the cerebrospinal fluid of eight 
patients \,·ith meningitis. India ink preparations dem-
onstrated encapsulated yeasts in all six patients with 
meningitis in whom this cerebrospinal fluid examina-
Ca 11.11' of deatli or 
Oulcollll' of Irralmpnl major complications 
Died afler 2 yr. of Unknown. Renal and congesli\e 
, treatment. heart failure 
Died 1 yr., i mo. after Posloperati\'e pulmonary emboli, 
treatment Staphylococcal septicemia. 
Died after 3 "k. of Pulmonary emboli. pneumonia 
trealment. and Klebsiella septicemia. 
Died after 5 mo. of !lIesenleric I'ein thrombosis. 
treatment. pulmonary emh:>Ii, .. 
pneumonIa, perItonitis. 
bacteroides and klebsiella 
septicemia 
Died 3 yr., 9 mo. after M)'ocardial infarction 
trealment. 
Alive> 1 ~rK after Renal failure due to chronic 
treatment. rejection. Pneumonitis, 
pneumocystis carinii? 
Alive> 1 yr. afler Recurrent pulmonary embolus. 
treatment. 
Alive 2 mo. after Renal failure due to chronic 
treatment. rejection. l"ocardia asteroides 
abscess. 
Alive, on treatment Cardiac an·h>thmia. 
for2mo. 
Alive> 1 }T. after Recurrent pulmonary embolus. 
treatment. 
tion was done. The infection was identified by needle 
biopsy in the patient wilh a granuloma of the left 
frontal lobe (E. \V.) (Fig. i), who was not subjected to 
lumbar puncture. Cerebrospinal fluid protein also "as 
eleyated in the patient I,·jlh cr}ptococcosis limited to 
the lungs (\1. Li.). 
Results of therapy. The cryptococcal infections \\-ere 
treated \,'ith amphotericin Band 5-fiuorocytosine 
alone or in simultaneous or sequential combination 
(Table IV). Immunosuppression was continued as 
considered necessary to avoid rejection of the graft. 
The duration of treatment was variable. 
The first two patients U. H., B. No) recei\'ed standard 
doses of intrayenous amphotericin B and additional 
amphotericin B intrathecally: J. H. received a total 
'dose of6.47 Gm. intravenously oyer a period of2 years 
and 5.25 mg. intrathecally gi\'en during the first 2 
months of treatment. The cerebrospinal fluid became 
normal during the fifth month of treatment. Cryp· 
tococci were found in India ink preparations and in 
cultures of cerebrospinal fluid onl)' during the firsl 
week of treatment and on one isolated occasion one 
year and 7 months after the beginning of treatment. j 
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T ble III Initial cerebro'pinal Auid findings in renal transplant recipients with CTvptococcosis a , 
Opmil/glcll),il1g 
I nit .. blood ails Cast pr .. ,;urt Red blood (fils 
.\'n . Patiellt (11111/. Hi)) (pa 1/1111.3) (per mm.') 
J. H. 1501- 185 247 
158* 34* 
2 B. N. 700/480 0 4 
3 R, K. 300!200 0 2 
4 M. La, -/- 0 -9 I-
S L.O. 280/- 14 29 
6 \V.S. 400/340 3 SO 
7 E.T. 240'170 0 140 
8 C.S. 190/- 0 14 
9 E. W. Not done. positive needle biopsy of brain 
10 M. Li. -/- 0 0 
-\'enlril-ulaT fluid. 
t:\O = nol done. 
\"hich was 3 months after temporary discontinuation of 
treatment. The major complication of the meningitis 
was increased intracranial pressure with signs of brain 
stem compression and diabetes insipidus. Twelye dap 
after drainage of "elltricubr fluid through a Rickham 
reservoir. a ventriculoperitoneal shunt \,·ith a low 
pressure Holter "ah'e was created, but it had to be 
removed 3Y2 months later because of Staph),lococcus 
rpidermidis infection. One month later a new ,'en-
triculoperitoneal shunt was implanted because of 
persistent increased illtracranial pressure which had 
resulted in cardiorespiratory arrest. The new shunt 
appeared to function for the rest of t he patient's life.' 
Severe low back pain and persistently high spinal fluid 
protein concentration in comparison to "entricular 
fluid suggested that the illtrathecal administration of 
amphotericin B might haye caused arachnoiditis. The 
high doses of intr.l\'enOHs amphotericin B ,,'ere 
followed by renal failure 11'2 years after the beginning 
of treatment. after '5 Gm. had been g1\'en. 
Hemodialysis became necessary one month later. The 
patient died 2 years after the detection of cryptococ-
cosis and 2 years and 10 rr:onths after transplantation. 
An autopsy was not performed, bur. renal failure with 
congestive heart failure \\'as the clinical cause of death, I 
Additional problems before he died included un-
explained fe\'er. malnutrition. \'omiting, diarrhea. and 
intermittent gastrointestinal hemorrhage. 
B. N. recei\'ed 1 Cm. of amphotericin B intra,'en-
ously and 17.5 mg. imrathecally oyer a period of i 
weeks. The India ink preparations of cerebrospinal 
fluid consistently demomtrated Cryptococci for 2 
months but the organi,m could be isolated in culture 
P.\lS Lyf/ph Prutein Glucose India ink 
(per min, 3) (pa ",m,3) (mg.ldl) (mg.ldl) pTt})aratiun Cu/tur' 
105 145 32 55 + + 
15* 18* 15* 105* ~ot +* 
0 4 3!l 30 + + 
0 2 42 55 + + 
23 49 145 44 ~l + 
i) 29 74 20 NO + 
10 70 83 6 + + 
7 133 60 29 + + 
3 11 16 51 + + 
0 0 86 83 Nega- !\ega· 
tive ti'·e 
only during the first 3 weeks oftreatment. Cerebrospi-
nal fluid findings became normal 5 months after 
treatment. Initially her condition deteriorated, ,,·ith 
signs of increased intracranial pressure, but she 
gradually improved after amphotericin B was discon-
tinued and replaced by 5-fluorocytosine (4 Gm. per 
day). which she continued to take for 5 months. She 
remained asymptomatic until her death from 
staphylococcal septicemia shortly after total hip ar-
throplasty for steroid arthropathy of the right hip .. -\t 
the time of death she also had chronic osteomyelitis. 
acute bronchopneumonia, acute purulent bacterial 
meningitis and cerebritis, and pulmonary emboli. She 
died 2 years and 4 months after transplantation. OiCe 
year and i months after treatment for cryptococcal 
meningitis. Autopsy revealed residual cryptococcal 
organisms in the basal ganglia. 
I n eight other patients subsequently treated for 
cryptococcosis. amphotericin B was used intravenously 
in smaller doses. starting with one to 3 mg. on the first 
day followed by increases of one to 2 mg, per day until 
a maimenance dose of 10 to 20 mg. per day \,as 
reached. After evidence of impro"ement, usually at the 
time \,'hen the maintenance dose was reached, it \,'as 
administered only every other day or less frequently. 
The total dose of amphotericin B was 385 to 8,10 mg. 
for fi'-e patients effectively treated with this regimer., 
No significant deterioration of renal function \,'as seell 
wit h these 10'" doses. 
One patient (L. 0.) was treated cffecth'ely with S-IO 
mg. of amphotericin B alone during 4 months. He 
sub~eqllently remained asymptomatic until death fro:Tl 
recurrent myocardial infarction 7* years after trans· 
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Fig. 1. ~cedle biopsy of the cerebral granuloma of Patient 9 (E. W,J sho',ing the yeasts s[2i ned by methenamine 
silver. (Original magnification. x280,) 
plantation or 3 years and 2 months after treatment. 
Ho\\e\'er. the protein concentration of his cerebrospi-
nal fluid remained elevated and at autopsy residual 
cryptococcal meningitis and infected mediastinal 
lymph nodes were found. 
Seven patients also received 5-fluoroqtosine with 
the amphotericin B. 'The usual dose was 150 mg. per 
kilogram daily divided into four oral doses. Three 
patients (W. S .• C. S .• E, W.) also taking azathioprine. 
including two patients with impaired renal function 
(W. S .. C. S,). developed reversible leukopenia neces-
sitating reduction or discontinuation of the 
5-Auorocytosine and the azathioprine. Two patients 
complained of loss of appetite and had diarrhea \"hile 
taking full doses of 5-fluoroc}tosine. 
The cell: ral nervous system infection of one patient 
E~1K La.) cleared under treatment with 5-AuorocYlOsine 
alone. but 2 months afta the beginning of treatment 
persistent urinary excretion of cryptococci. still sensi-
ti"e to 5-A lIorocytosine. subsided onl} after the aclcli-
tion of small doses ( 15 mg, per day) of am photericin B. 
This patient died after 5 months of treatment. 7 years 
and 2 nlOnths after transplantation, from mesenteric 
vein thrombo:;is. bowel gangrene. septicemia. and 
pulmonary emboli. ~o residual cryptococcal illfection 
was found at autopsy. 
One patient (R. K.) died 3 weeks after the beginning 
of 5-Auoroc} tosine treatment and one week after 
addition of amphotericin B, one year and 4 months 
after his third, transpbnr. His death was caused by 
massive pulrllonar} embc,li and infection. but residual 
cryptococcal meningitis sti!! \,'as present at autopsy. 
The five patients treated most recently-four I"ith 
central nenOllS system infection (E_ T_. \\'. So. C. S,. E. 
\\'.) a nd one with pulmonary cr~ prococcosis (\1. 
Li.)-all were treated from the beginning I\'ith a 
combination of amphC1teriLin Band 5-flllorocytosine in 
the doses olltlincd for a period of 12 weeks. In all 
patients the infection responded promptly to (rea't-
ment. Threc patielJts (E. T. W_ S .• M_ Li,) h:ne 
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Table IV Treatment of cnptococcosis in ten transplant patients . . 
,-llllphfOlrricil1 B 
C(lJt Dflily d{.sl' I Total do,e I Dllraliull of .\'0. Pa/ifnt tmg.) (mg.) treotment 
J. H. 1 to -10 6.-170 2 yr. 
2 B. N. 1 to -10 1.000 7 wk. 
3 R.K. 1106 21 6days 
4 M. La. I to 15 195 4 wk. 
5 L.O. 3 to 20 840 4 mo. 
6 \V.S. 1 to 15 565 12 wk. 
7 E. T. 1 to 20 810 12 wk. 
8 C. S. 1 to 10 385 3 mo. 
g E.W. I to 20 428 >2mo. 
10 M. U. 1 to 20 450 12 wk. 
remained asymptomatic and \dthout recurrence for 
oyer a year after treatment. One patiel1l (c. S.) has just; 
completed treatment. The Outcome of continuous 
treatment. started 2 months ago in the patient (E. W.) 
\,-ith a large cerebral granuloma in the left frontal lobe. 
is undetermined at present. 
Associated problems idelllified in these fi\-e suniving 
patients have included pulmonary emboli 1~fK Li., E. 
T.). renal failure due to chronic rejection (\\'. S .. e. S.). 
multiple squamous cell carcinoma of the skin (W. S.), 
herpetic stomatitis (\\'. S.), possible pneumocystis 
carlnll pneumOllltIs (treated \,·ith Pentamidine 
isethionate) (W. S.). abscess of the thigh dut'" toSocGrdia 
aJieroides (C. S.), unexplained li\'er dysfunction (e. S.). I 
and cardiac arrhythmia \,·ith atrial fibrillation (E. W.). 
One patient (W. S.I aho has residual ataxia follt)\"il1g 
cryptococcal meningitis but also follo\"ing gentamicin 
administration. 
DISCUSSION 
Cryptococci are Yt:'astlike fungi widcl~ di5tribuled in 
natu\"e. CI),P'OCO(CUS 1/('(10 rma JlS is the onh' ~peCles 
5-jlIlOr('(j/osil1t 
Dail. dll~ I Dllratiall of (Cm.1 tTfatmerll 
none none 
-I 5 mo. 
12 3 wk. 
8 to 12 18 wk. 
0 0 
4 to 8 12 wk. 
12 12 wk. 
1.5 1 mo. 
10-4-8 >2 mo. 
8-12 12 wk. 
Remarks 
- -
.. 
+.:>.2.:> mg, AmphotenclIl B 
intr;Jthecally 
Amphotericin B replaced by 
5·AuorOcYtosine. + ) 7.5 
mg. Amphotericin B 
intrathecally 
Amphotericin B added 2 \\L 
after beginning of 
5-AuoTOC)10si ne 
Amphotericin B added 2 mo. 
after beginning of 
5-fluorOC\'losine 
Amphoteri~in B alone 
Amphotericin B + 5-
fluoroqtosine 
simultaneously 
Amphotericin B 
+ 5-Auorocytosine 
simultaneously 
Amphotericin B 
+ 5·fluoroc)'tosine 
simultaneously 
Amphotericin B 
+ 5-Auorocytosine 
simultaneously 
Amphotericin B 
+ 5-fluoroc),!osine 
simultaneously 
knO\,",l to cause disease in man. Cryptococci have been 
found in soil. especially in soil containing bird drop-
pings: but they also bave been identified in man as a 
saprophyte 011 the skin. in the respiratory tract, and in 
the gasrroimestinal tractY· 29 C1)'PIOCOCCUS Ill?oJon!lGIU 
has a capsule of polysaccharides which contributes to 
its pathogenicity by protecting the organism from 
being phagocytosed by leukocytes and macrophages.'· 
10 This capsule may prevent an acute infiammalOl'Y 
response, usually absent with cryptococcal infections! 
especially of the central nervous srstemI~U by co\'ering 
other fungal antigens and pre"enting host sensitization 
to the~e more potent fungal antigensl9• 
The capacity to form this capsule is determined not 
onl~ genetically but also by the ellvironment.!S Capsule 
formation requires available free water and is an 
cn~rgyD-consuming metabolic process. Dnder certain 
gro\\th conditions. such as in soil with high mineral 
content or in culture medium "'ith high osmolal·ity. the 
fungus is unable to produce a capsule. IS Because of the 
smaller size of nonencapsulated \'ariallls, these can be 
expected to h3\'e a greater chance of passing through 
the:' hlllll.1II UI'p'-'r ropil ;lton tr:tct and reaching the 
lun~s afler inh;d:llion.' Inh:tialion of tht: smaller 
nl~t:ncapsllble:d flflfl~ ;ltlll;til~ may be the most 
com mon lIlode: "f ill fl'l I iOIl. III I he Illngs the orga nisms 
find ,\II t'll\irOl1l11e:nt 1';\, ".-ahle for cap,ule formation; 
hO\\·C'\c:r.lhe: high nalllr;t! inllllullity orman against the 
nOIlC'llcotp,ulatccl fortll. \\ hi, It ~til1l11y;rtt:p an inflam-
m:llur~ rcspPII:>ei" ami i~ readil~ phagocytosed,9. 10 may 
account fur Ihe: illfre:(llII .. ·ltl IllTlIlTence of cryptococcal 
disease despite the lffan~ opportunities for exposure. 
The incidC'ntal autopsy finding of primary pulmonary 
cryptococcal cumplexes. with subpleural pulmonary 
granuloma and hilar Iyrnphnodes containing Cr;;Plococ-
(lIS 11 1'0/0 rma liS. is COnSi!ilcnt with the hypothesis that 
inhalation is a common route ofinfection.:tl Inhalation 
of organisms can n:slllt in colonization or disease of the 
respiratory trac!.:!3· ~lK U Following dissemination. the 
infc!Ction has a tendellc~ to localize in the central 
nervous system. II. H. 17 although ct:ntral nenous system 
in\'ol\'ement may not become apparent until pulmo-
nary imolvement no longer is detectable. Pulmonary 
infection was evident in onl)" two of ollr nine patients 
with central nervous system in fection (E. T.. J.. H.); in 
one other patient (L.. 0.) infected mediastinal Iymph-
nodes were found at autopsy yeal's later. 
Compromise of host defense mechanisms due to 
immunosuppressive therapy or malignancy can be 
found in a significant number of patients with cryp-
tocoecal infections. 13• 21. ~~ HO\\·ever. only a fel\' cases of 
this complication after renal transplantation have been 
reported.33. 3lI. 39 
I n our experience cryptococca I in fections usually 
occur late after transplantation and therefore this 
~nfection might not ha\'e been included in an earlier 
publication from this center concerning fungal infec-
tions after transplantalion. 31 The late appearance of 
this disease suggests acquisition of this infection under 
immunosuppression rather than exacerbation of a 
pre-existing. inapparent infection. which might be 
expected to reveal itself earlier after initial intensi\'e 
immunosuppression. However. the time of acquisition 
remains uncertain because of the insidious nature of 
this infection. III three of our patients. an exacerbation 
of symptoms was obsen'ed after a temporary increase 
of cnrticosteroid therapy. In rats and guinea pigs. 
reactivation of experimental cryptococcal infection 
under the influence of corticosteroids has been oh-
sened.zo and the possibilit~ of autogenous reinfection 
from an inapparent fuCtI' call not be ruled out. 
The clinical manifestations of cryptocoecal infection 
of the central nervous sy~tent were mainly signs of 
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disturbed brain function and increased intracranial 
pressure. frequently creating a suspicion of brain 
tumor and directing initial studies to seal'ch for a 
space-occll p~ i ng lesions: ho\\·e\'er. such a lesion was 
detected in onl~ one patient (E. W.). Fever and 
meningeal signs freqllentl~ were absent. Spi nal fluid 
analyses indicated only mild inflammation. 
'. ' 
In the majorit)" of patients the central nen-ous 
system infection remains limited to the meninges .. 
Cerebral granulomata were found in onl}' one of our 
patients and are rare; onl~D 26 cases ha\'e been 
described in the English language medical literature, 
compared to several hundred cases of cryptococcal 
meningitis.7 . 12. -12 The majority of patients with 
cryptococcal granulomata of the brain or spinal cord 
have an as,ociated meningitis. The development of 
granulomata can be considered a late complication of a 
meningeal infection with extension into the gray 
matter from an adjacent meningeal focus. 
In mice it has been 5hO\\I1 that the reaction of the 
host to the presence of encapsulated CI)plococcus 
neofol'mam is organ dependent.26 The encapsulated 
yeast or capsular polysaccharides evoke almost no 
inflammation and the organisms tend to persist if 
directly inoculated into the brain of the animal. On the 
other hand intraetitaneous or intraperitoneal inocula-
tion is follO\\ed by inflammation and elimination of the 
yeast by phagocytosis. 
Lack of an exudative inflammation also is charac-
teristic of human cryptococcosis of the central nervous 
system. 2• 2. The inflammation found at autopsy after 
death from cryptococcal meningiti~ frequently is nor 
extensive enough to explain death. Increased intracra-
nial pressure due to cerebral edema. impaired cere-
brospinal fluid circulation. and metabolic effects ap-
pears to p1a~ an important role in the morbidity and 
mortality rates of patients \dth cryptococcal menin-
gitis. The effect of increa:;ed intracranial pressure is 
well illustrated by our patient who required ven-
triculoperitoaeal shunting. as \\'ell as by reported cases 
benefiting fryK~m interlllittem or cOlI!inuulIs remo\'al of 
cerebrospinal fluid. 3• U Immunosuppressive therapy. 
including corticosteroids. can be expected to defa~ 
elimination of the fungu, from the respiratory tract 
following inh:1lalion. to acri\"3Ie a d,xJlIant focus. and 
to increase Ihe risk of dissemination. The cuntI"ihution 
of curticosteroids to the modification uf an established 
central nenotl, system infection is less certain. Cor-
ticostt:roids at least might be expected to alle\'iate 
temporali" the increased illlracrani:ll pressure and the 
papilledema \\'hich rapidly appeared in t\\'O of OUI' 
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patients after withdra\\'al of high corticost~roid 
doses. 
Therapy "'ith all1pholcl'icin B has improved the 
progno~is of cryptococcal meningitis. II. H. 17. 3l Our 
approach to therapy ,\'ith .lmphotcricin B doses was 
based on the recommendation of Drut.l and co· 
\\'orkers,16 Lo\\' doses permit prolonged therap\' with-
out irrcversible renal damage. \"hich is rebted to the 
total amollnt of amphotericin B receiyed.-H The nature 
of crrptococcal infection and the tendency to relapse 
after treatment makes prolonged trefltmellt ad\'isable. 
Amphotericin B attache~ to the sterols of cell 
membranes and its actiyDit~I against fungi is due to 
interruption of the integrity of cell membranes,ls 
Amphotericin B has unusual phannacokinetics4 in that 
it disappears rapidly from the circulation after in-
travenous infusion because of either storage at un-
known sites or rapid inacti\'ation; only a small amount 
of the administered dose is detectable in the urine. The 
persistence of low serum le\'cIs and continuous excre-
tion in the urine for weeks after therapy suggests early 
storage foUowed by slow return to the circulation, 
rather than rapid inacti\'ation. Satur,)-tion of cellular 
binding sites, including those of fungi. may be 
responsible for the therapeutic effect of low doses of 
amphotericin B given oyer a prolonged period of time, 
following which therapeutic serum and cerebrospinal 
fluid concentrations cannot be expected. An immediate 
response to therapy cannot be expected with this low 
dose approach. Early in therapy, l>rc\'ention of in-
creased intracranial pressure by corticosteroid ad-
ministration or by temo\'al of spinal fluid may be ' 
important, as illustrated by a patient treated with a 
combination of these measures by Ikemoto and 
associates. If 
Five-fluorocytosine is a newer antifungal agent used 
for the treatment of cryptococcal infections.22• 41 It 
interferes with nucleic acid synthesis in the yeast cell 
nucleus. It has many ad\'antages over amphotericin B • 
including good absorption from the gastrointestinal 
tract after oral administration. good tissue penetration, 
and much less toxicity. IL is not metabolized in the 
human body and 90 percent is excreted by the kidney, 
necessitating dose adjustme~t in the presence of renal 
failure. 34 In spite of these phar'macological ad\'antages, 
5-fluorocytosine has not replaced amphotericin B for 
the treatment of cryptococcal meningitis. Only 50 
percent of patients primarily treated ha\'c had a good 
therapeUlic rcsponse and the relapse rate was high.' 
Thesc disappointing results may be explained by the 
tendency of Cryptococcus strains to become resistant to 
C')ptlJ(o((()sis aftrr rmol trQI!Splulltatioll 2i5 
5-fluorocytosine' during treatment and by the need for 
prul"nged treatmcnt. \\'e treated only one patient 
primarily ,\,ith 5-fluorocytosine alone, and there was 
remission of his meningitis. although persistent fun-
guria sub~ided only after the addition of small do~es of 
amphotericin B. In our other patients 5-fluorocytosine 
was used in combination with amphotericin B. A syner-
gistic effect has been demonstrated for these two 
agems,30 possibly based on the increased penetration 
of,5-fluorocytosine into yeast cells with membranes 
damaged by exposure to amphotericin B.3S .-\mphoteri-
cin B also has shown to delay de\'e!opment of 
5-fluorocytosine resistance in experimental crypto-
coccal infection in mice.s Better results with 
5-fluoroc}'tosine have been obtained in patients failing 
to respond to initial amphotericin B therapy.! The 
available information about the pharmacokinetics of 
amphotericin B suggests that residual amphotericin B 
may enhance the 5-fluorocytosine effect. 
The final outcome of the treated cryptococcal 
meningitis is known in five of the ten transplant 
patients who died after treatment (Table II). One 
patient died early in the course of treatment for 
cryptococcal meningitis and the' other four patients 
died 5 months to four years after detection of the 
infection. No dcath could be attributed to the cryp-
tococcal infection. Four patients died of vascular or 
septic complications or both. The cause of death of one 
patient is uncertain. Although therapy appeared 
clinically to havc been effective in all five patients who 
died. residual organisms were found years after 
treatment in two patients. Three of the fi"e lil'ing 
patients have been obsen'ed for oyer one lear after 
treatment. All five of these patients have no clinical 
signs of cryptococcosis. 
ADDENDUM 
Since this paper was completed, an additional patient (C. S.) 
died from multiple organ failure. unrelated to the pre\10us 
cryptococcal meningitis. At autopsy. 7 weeks after completion 
of therapy. slight fibrosis of the leptomeninges. wilh scattered 
macrophages, was observed. but no cryptococci were iden-
tified in the brain. 
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